drugset / Trial / NCT00485407
Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to test the value of dose increases in patients with residual ADHD symptoms after treatment with the usual target dose of atomoxetine
Timeline
- Start
- 2003-07
- Primary completion
- —
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | — | — |